Senior Director, Clinical Supply Chain

Opportunity awaits those up to the challenge of developing transformative therapies across a broad range of debilitating diseases.

Summary:

Roles and Responsibilities:

• Responsible for clinical supply team for on-going and new clinical trials by ensuring on-time delivery, including demand forecasting, trial monitoring & resupply planning, IRT set-up and distribution activities.
• Oversight for the design and execution of packaging and labeling campaigns with clinical packaging and labeling vendors.
• Lead the label text, proof and variable text processes from generation through approval for open and blinded clinical labels with a single or multiple languages.
• Manage the storage, distribution and inventory tracking through the supply chain in accordance to relevant regulations.
• Develop tracking systems documenting lot usage per clinical trial to ensure proper accountability and genealogy.
• Manage vendor selection related to packaging, labeling and distribution, and any others as required. Work with stakeholders as required in selection/qualification of CMO's and to negotiate effective supply and technical agreements.
• Build and maintain effective business relationships with vendor portfolio, ensuring objectives are being met based on quality, cost and performance.
• Facilitate and manage productive team communication and collaboration, both internally and externally.
• Passion for learning, creating, relating, communicating, and leading cross functional teams.
• 10+ years of progressive experience in biopharma.
• The ideal candidate should have a Bachelor's degree in life sciences /engineering or relevant work experience.

Travel Requirements:

Education:

Pay Information:

Work Arrangement:

Benefits and Perks:

Apellis offers a comprehensive benefits package, including a 401(k) plan with company match, inclusive family building benefits, flexible time off, summer and winter shutdowns, paid family leave, disability and life insurance, and more! Visit https://apellis.com/careers/benefits/ to learn more.

Company Background:

Apellis Pharmaceuticals, Inc. is a global biopharmaceutical company leading the way in complement science to develop life-changing therapies for some of the most challenging diseases patients face. We ushered in the first new class of complement medicine in 15 years and now have two C3-targeting medicines approved to treat four serious diseases. Breakthroughs for patients include the first-ever therapy for geographic atrophy, a leading cause of blindness, and the first treatment for patients 12 and older with C3G or primary IC-MPGN, two severe, rare kidney diseases. We believe we have only begun to unlock the potential of targeting C3 across many serious diseases.

For more information, please visit http://apellis.comor follow us on LinkedIn andX.

EEO Statement:

Apellis is an equal opportunity employer and complies with all applicable federal, state and local fair employment practices laws. Apellis strictly prohibits and does not tolerate discrimination against employees, applicants or any other covered persons because of race, color, religion, creed, national origin or ancestry, ethnicity, sex (including pregnancy), gender (including gender nonconformity and status as a transgender or transsexual individual), age, physical or mental disability, citizenship, past, current or prospective service in the uniformed services, genetic information, marital status, AIDS/HIV status, smoker/nonsmoker, and occupational pneumoconiosis or any other characteristic protected under applicable federal, state or local law.
For San Francisco postings: Pursuant to the San Francisco Fair Chance Ordinance, we will consider for employment qualified applicants with arrest and conviction records.

Other Duties:

Please note this job description is not designed to cover or contain a comprehensive listing of activities, duties or responsibilities that are required of the employee for this job. Duties, responsibilities and activities may change at any time with or without notice.